nodes	percent_of_prediction	percent_of_DWPC	metapath
Altretamine—Neoplasm—Formoterol—chronic obstructive pulmonary disease	0.0467	0.0467	CcSEcCtD
Altretamine—Neoplasm—Arformoterol—chronic obstructive pulmonary disease	0.0467	0.0467	CcSEcCtD
Altretamine—Vertigo—Roflumilast—chronic obstructive pulmonary disease	0.04	0.04	CcSEcCtD
Altretamine—Ataxia—Salbutamol—chronic obstructive pulmonary disease	0.0333	0.0333	CcSEcCtD
Altretamine—Decreased appetite—Roflumilast—chronic obstructive pulmonary disease	0.0316	0.0316	CcSEcCtD
Altretamine—Fatigue—Roflumilast—chronic obstructive pulmonary disease	0.0313	0.0313	CcSEcCtD
Altretamine—Neuropathy peripheral—Montelukast—chronic obstructive pulmonary disease	0.0278	0.0278	CcSEcCtD
Altretamine—Neuropathy peripheral—Salbutamol—chronic obstructive pulmonary disease	0.0268	0.0268	CcSEcCtD
Altretamine—Asthenia—Roflumilast—chronic obstructive pulmonary disease	0.0261	0.0261	CcSEcCtD
Altretamine—Convulsion—Aminophylline—chronic obstructive pulmonary disease	0.0257	0.0257	CcSEcCtD
Altretamine—Dizziness—Roflumilast—chronic obstructive pulmonary disease	0.024	0.024	CcSEcCtD
Altretamine—Vomiting—Roflumilast—chronic obstructive pulmonary disease	0.0231	0.0231	CcSEcCtD
Altretamine—Anorexia—Aminophylline—chronic obstructive pulmonary disease	0.0231	0.0231	CcSEcCtD
Altretamine—Nausea—Roflumilast—chronic obstructive pulmonary disease	0.0216	0.0216	CcSEcCtD
Altretamine—Decreased appetite—Aminophylline—chronic obstructive pulmonary disease	0.0211	0.0211	CcSEcCtD
Altretamine—Convulsion—Montelukast—chronic obstructive pulmonary disease	0.0192	0.0192	CcSEcCtD
Altretamine—Vertigo—Salbutamol—chronic obstructive pulmonary disease	0.0192	0.0192	CcSEcCtD
Altretamine—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.0177	0.0177	CcSEcCtD
Altretamine—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.0166	0.0166	CcSEcCtD
Altretamine—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.016	0.016	CcSEcCtD
Altretamine—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.0159	0.0159	CcSEcCtD
Altretamine—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.0159	0.0159	CcSEcCtD
Altretamine—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.0156	0.0156	CcSEcCtD
Altretamine—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.0154	0.0154	CcSEcCtD
Altretamine—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.0154	0.0154	CcSEcCtD
Altretamine—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.0151	0.0151	CcSEcCtD
Altretamine—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.0151	0.0151	CcSEcCtD
Altretamine—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.015	0.015	CcSEcCtD
Altretamine—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.0145	0.0145	CcSEcCtD
Altretamine—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0144	0.0144	CcSEcCtD
Altretamine—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.0136	0.0136	CcSEcCtD
Altretamine—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.0132	0.0132	CcSEcCtD
Altretamine—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.0132	0.0132	CcSEcCtD
Altretamine—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.013	0.013	CcSEcCtD
Altretamine—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.0125	0.0125	CcSEcCtD
Altretamine—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.0122	0.0122	CcSEcCtD
Altretamine—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.0122	0.0122	CcSEcCtD
Altretamine—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.0119	0.0119	CcSEcCtD
Altretamine—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.0117	0.0117	CcSEcCtD
Altretamine—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.0117	0.0117	CcSEcCtD
Altretamine—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.0115	0.0115	CcSEcCtD
Altretamine—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.0115	0.0115	CcSEcCtD
Altretamine—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.0112	0.0112	CcSEcCtD
Altretamine—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.0111	0.0111	CcSEcCtD
Altretamine—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.011	0.011	CcSEcCtD
Altretamine—Nausea—Formoterol—chronic obstructive pulmonary disease	0.011	0.011	CcSEcCtD
Altretamine—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.011	0.011	CcSEcCtD
Altretamine—Nausea—Montelukast—chronic obstructive pulmonary disease	0.0107	0.0107	CcSEcCtD
Altretamine—Convulsion—Prednisolone—chronic obstructive pulmonary disease	0.0106	0.0106	CcSEcCtD
Altretamine—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.0103	0.0103	CcSEcCtD
Altretamine—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.00822	0.00822	CcSEcCtD
Altretamine—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.00799	0.00799	CcSEcCtD
Altretamine—Convulsion—Prednisone—chronic obstructive pulmonary disease	0.00771	0.00771	CcSEcCtD
Altretamine—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.00692	0.00692	CcSEcCtD
Altretamine—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.00661	0.00661	CcSEcCtD
Altretamine—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.00631	0.00631	CcSEcCtD
Altretamine—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.00626	0.00626	CcSEcCtD
Altretamine—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.00593	0.00593	CcSEcCtD
Altretamine—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.00521	0.00521	CcSEcCtD
Altretamine—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.0048	0.0048	CcSEcCtD
Altretamine—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.00462	0.00462	CcSEcCtD
Altretamine—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00431	0.00431	CcSEcCtD
